Small molecules targeting p53 to improve antitumor therapy
- PMID: 18691143
- DOI: 10.2174/138955708785132774
Small molecules targeting p53 to improve antitumor therapy
Abstract
Small molecules targeting p53 represent an emerging group of potentially useful agents for the improvement of antitumor therapy. These modulators include agents that activate wild-type p53 or reactivate mutant p53 and inhibitors of p53 functions. Preclinical evidences support the interest of combination strategies with conventional antitumor agents.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
